Citations Report

Clinical Investigation : Citations & Metrics Report

Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.

Clinical Investigation has got h-index 21, which means every article in Clinical Investigation has got 21 average citations.

Following are the list of articles that have cited the articles published in Clinical Investigation.

  2020 2019 2018 2017 2016

Year wise published articles

28 19 22 19 2

Year wise citations received

222 233 233 230 181
Journal total citations count 1936
Journal impact factor 6.44
Journal 5 years impact factor 12.56
Journal cite score 10.78
Journal h-index 21
Journal h-index since 2016 18
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
  • Miller F, Björnsson M, Svensson O, Karlsten R (2014) Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis. Contemporary clinical trials 37: 189-199.

    View at Publisher | View at Google Scholar
  • Cuffe RL, Lawrence D, Stone A, Vandemeulebroecke M (2014) When is a seamless study desirable? Case studies from different pharmaceutical sponsors. Pharmaceutical statistics 13: 229-237.

    View at Publisher | View at Google Scholar
  • Elsäßer, Amelie, et al. "Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency." Trials 15.1 (2014): 1-10. View at Publisher | View at Google Scholar | View at Indexing
  • Pallmann, Philip, et al. "Adaptive designs in clinical trials: why use them, and how to run and report them." BMC medicine 16.1 (2018): 1-15. View at Publisher | View at Google Scholar | View at Indexing
  • Esparza J (2013) A brief history of the global effort to develop a preventive HIV vaccine. Vaccine 31: 3502-3518.

    View at Publisher | View at Google Scholar
  • Excler JL, Tomaras GD, Russell ND (2013) Novel directions in HIV-1 vaccines revealed from clinical trials. Current opinion in HIV and AIDS 8: 421-431.

    View at Publisher | View at Google Scholar
  • A Day T, G Kublin J (2013) Lessons learned from HIV vaccine clinical efficacy trials. Current HIV research 11: 441-449.

    View at Publisher | View at Google Scholar
  • Lithgow KV, Cameron CE (2017) Vaccine development for syphilis. Expert Review of Vaccines 16: 37-44.

    View at Publisher | View at Google Scholar
  • Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, et al. (2014) Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery. Clinical infectious diseases 58: 1312-1321.

    View at Publisher | View at Google Scholar
  • Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, et al. (2014) An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. PloS one 9: 86719.

    View at Publisher | View at Google Scholar
  • Olson AD, Guiguet M, Zangerle R, Gill J, Perez-Hoyos S, et al. (2014) Evaluation of rapid progressors in HIV infection as an extreme phenotype. JAIDS Journal of Acquired Immune Deficiency Syndromes 67: 15-21.

    View at Publisher | View at Google Scholar
  • Giganti MJ, Luz PM, Caro-Vega Y, Cesar C, Padgett D, et al. (2015) Koenig S, Echevarria J, McGowan CC, Shepherd BE. A comparison of seven cox regression-based models to account for heterogeneity across multiple HIV treatment cohorts in Latin America and the Caribbean. AIDS research and human retroviruses 31: 496-503.

    View at Publisher | View at Google Scholar
  • Judd A, Duong T, Galli L, Goetghebuer T, Ene L, et al. (2014) Post‐licensing safety of fosamprenavir in HIV‐infected children in Europe. pharmacoepidemiology and drug safety 23: 321-325.

    View at Publisher | View at Google Scholar
  • Gourlay, Annabelle, et al. "The human immunodeficiency virus continuum of care in European Union countries in 2013: data and challenges." Clinical infectious diseases 64.12 (2017): 1644-1656. View at Publisher | View at Google Scholar | View at Indexing
  • Olson, Ashley D., et al. "An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration." PloS one 9.1 (2014): e86719. View at Publisher | View at Google Scholar | View at Indexing
  • Engsig, Frederik N., et al. "Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery." Clinical infectious diseases 58.9 (2014): 1312-1321. View at Publisher | View at Google Scholar | View at Indexing
  • Donaldson, Amy E., et al. "Addressing the needs of adolescents with treatment resistant depressive disorders: a systematic review of rTMS." Brain Stimulation 7.1 (2014): 7-12. View at Publisher | View at Google Scholar | View at Indexing
  • Gordon, Michael, and Glenn Melvin. "Risk assessment and initial management of suicidal adolescents." Australian family physician 43.6 (2014): 367-372. View at Publisher | View at Google Scholar | View at Indexing
  • Huang, David T., et al. "Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome." Annals of the American Thoracic Society 14.1 (2017): 124-133. View at Publisher | View at Google Scholar | View at Indexing
  • Yehya, Nadir, et al. "Reappraisal of ventilator-free days in critical care research." American journal of respiratory and critical care medicine 200.7 (2019): 828-836. View at Publisher | View at Google Scholar | View at Indexing
  • Qin, Xuemei, et al. "Discovery of new [1, 4] dioxino [2, 3-f] quinazoline-based inhibitors of EGFR including the T790M/L858R mutant." Bioorganic & medicinal chemistry 24.13 (2016): 2871-2881. View at Publisher | View at Google Scholar | View at Indexing
  • Zhou, Wei, et al. "Discovery of Pteridin-7 (8 H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) Kinase T790M/L858R mutant." Journal of medicinal chemistry 56.20 (2013): 7821-7837. View at Publisher | View at Google Scholar | View at Indexing
  • Mah, Robert, Jason R. Thomas, and Cynthia M. Shafer. "Drug discovery considerations in the development of covalent inhibitors." Bioorganic & medicinal chemistry letters 24.1 (2014): 33-39. View at Publisher | View at Google Scholar | View at Indexing
  • Cherubini, Antonio, and Peter Crome. "The exclusion of older subjects from clinical trials: the PREDICT study." Clinical trials in older adults (2015): 1-22. View at Publisher | View at Google Scholar | View at Indexing
  • Shepherd, Thomas A., et al. "Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson’s disease without cognitive impairment." Pilot and feasibility studies 4.1 (2018): 1-12. View at Publisher | View at Google Scholar | View at Indexing
  • Jenkinson, Paul M., et al. "The role of reality monitoring in anosognosia for hemiplegia." Behavioural Neurology 23.4 (2010): 241-243. View at Publisher | View at Google Scholar | View at Indexing
  • Bartlam, Bernadette, et al. "The role of qualitative research in clinical trial development: the EASE Back study." Journal of Mixed Methods Research 12.3 (2018): 325-343. View at Publisher | View at Google Scholar | View at Indexing
  • Farrand, Paul, et al. "Psychological interventions to improve psychological well-being in people with dementia or mild cognitive impairment: systematic review and meta-analysis protocol." BMJ open 6.1 (2016): e009713. View at Publisher | View at Google Scholar | View at Indexing
  • Parsons, Suzanne, et al. "What the public knows and wants to know about medicines research and development: a survey of the general public in six European countries." BMJ open 5.4 (2015): e006420. View at Publisher | View at Google Scholar | View at Indexing
  • De Spiegeleer, Bart, et al. "Regulatory development of geriatric medicines: to GIP or not to GIP?." Ageing research reviews 27 (2016): 23-36. View at Publisher | View at Google Scholar | View at Indexing
  • Lacey, Rosie J., et al. "Evidence for strategies that improve recruitment and retention of adults aged 65 years and over in randomised trials and observational studies: a systematic review." Age and Ageing 46.6 (2017): 895-903. View at Publisher | View at Google Scholar | View at Indexing
  • Crome, Peter, Antonio Cherubini, and Joaquim Oristrell. "The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond." Expert review of clinical pharmacology 7.4 (2014): 457-468. View at Publisher | View at Google Scholar | View at Indexing
  • Barton, Samantha, et al. "Clinical effectiveness of interventions for treatment-resistant anxiety in older people; a systematic review." Health Technology Assessment 18.50 (2014): 1-60. View at Publisher | View at Google Scholar | View at Indexing
  • Hughes-Morley, Adwoa, et al. "Factors affecting recruitment into depression trials: systematic review, meta-synthesis and conceptual framework." Journal of affective disorders 172 (2015): 274-290. View at Publisher | View at Google Scholar | View at Indexing
  • Rouette J, Blazeby J, King M, Calvert M, Peng Y, et al. (2015)Meyer RM, Ringash J, Walker M, Brundage MD. Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives. Quality of Life Research 24: 1317-1325.

    View at Publisher | View at Google Scholar
  • Bantug ET, Coles T, Smith KC, Snyder CF, Rouette J, Brundage (2016) Graphical displays of patient-reported outcomes (PRO) for use in clinical practice: What makes a pro picture worth a thousand words?. Patient education and counseling 99: 483-490.

    View at Publisher | View at Google Scholar
  • Bratton DJ. Design issues and extensions of multi-arm multi-stage clinical trials (Doctoral dissertation, UCL (University College London)). View at Publisher | View at Google Scholar | View at Indexing
  • Dauti A, Gerstl B, Chong S, Chisholm O, Anazodo A (2017) Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients. Journal of Adolescent and Young Adult Oncology. 2017 Feb 16.

    View at Publisher | View at Google Scholar
  • Tan CJ, Yang JL, Crowe P, Goldstein D (2013) Targeted therapy in soft tissue sarcoma—a novel direction in therapeutics. Chinese clinical oncology 2. View at Publisher | View at Google Scholar | View at Indexing
  • Rothschild SI, Gautschi O, Batliner J, Gugger M, Fey MF, et al. (2016) MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors. Lung Cancer. View at Publisher | View at Google Scholar | View at Indexing
  • Amarilyo G, Lourenço EV, Shi FD, La Cava A (2014) IL-17 promotes murine lupus. The Journal of Immunology 193: 540-243.

    View at Publisher | View at Google Scholar
  • Santoro, Nanette, et al. "Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement." The Journal of Clinical Endocrinology & Metabolism 101.4 (2016): 1318-1343. View at Publisher | View at Google Scholar | View at Indexing
  • Durham NC. Personal Information Name: Prema Menezes.

    View at Publisher | View at Google Scholar
  • Jang IS, Neto EC, Guinney J, Friend SH, Margolin AA (2014) Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data. InPacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2014 (p. 63). NIH Public Access.

    View at Publisher | View at Google Scholar
  • Wheeler DB, Zoncu R, Root DE, Sabatini DM, Sawyers CL (2015) Identification of an oncogenic RAB protein. Science 350: 211-217.

    View at Publisher | View at Google Scholar
  • Jang IS, Dienstmann R, Margolin AA, Guinney J (2015) STEPWISE GROUP SPARSE REGRESSION (SGSR): GENE-SET-BASED PHARMACOGENOMIC PREDICTIVE MODELS WITH STEPWISE SELECTION OF FUNCTIONAL PRIORS. InPacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 20: 32.

    View at Publisher | View at Google Scholar
  • Ennis L, Wykes T (2013) Impact of patient involvement in mental health research: longitudinal study. The British Journal of Psychiatry 203: 381-386.

    View at Publisher | View at Google Scholar
  • Sin J, Henderson C, Spain D, Gamble C, Norman I (2016) What factors influence successful recruitment of siblings of individuals with first episode psychosis to e‐health interventions? A qualitative study. Health Expectations.

    View at Publisher | View at Google Scholar
  • Ziegler D, Fonseca V (2015) From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathy. Journal of Diabetes and its Complications 29: 146-156. View at Publisher | View at Google Scholar | View at Indexing
  • O’Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM. A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program. Drugs. 2014 Jan 1;74(1):15-30. View at Publisher | View at Google Scholar | View at Indexing

Relevant Topics